• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊椎动物各物种动物癌症中肽基精氨酸脱亚氨酶和蛋白质脱亚氨作用的初步研究

A Pilot Study on Peptidylarginine Deiminases and Protein Deimination in Animal Cancers across Vertebrate Species.

机构信息

School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK.

School of Human Sciences, London Metropolitan University, London N7 8DB, UK.

出版信息

Int J Mol Sci. 2022 Aug 4;23(15):8697. doi: 10.3390/ijms23158697.

DOI:10.3390/ijms23158697
PMID:35955829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9368843/
Abstract

PADs are a group of calcium-dependent enzymes that play key roles in inflammatory pathologies and have diverse roles in cancers. PADs cause irreversible post-translational modification of arginine to citrulline, leading to changes in protein function in different cellular compartments. PAD isozyme diversity differs throughout phylogeny in chordates, with five PAD isozymes in mammals, three in birds, and one in fish. While the roles for PADs in various human cancers are mounting (both in regards to cancer progression and epigenetic regulation), investigations into animal cancers are scarce. The current pilot-study therefore aimed at assessing PAD isozymes in a range of animal cancers across the phylogeny tree. In addition, the tissue samples were assessed for total protein deimination and histone H3 deimination (CitH3), which is strongly associated with human cancers and also indicative of gene regulatory changes and neutrophil extracellular trap formation (NETosis). Cancers were selected from a range of vertebrate species: horse, cow, reindeer, sheep, pig, dog, cat, rabbit, mink, hamster, parrot, and duck. The cancers chosen included lymphoma, kidney, lung, testicular, neuroendocrine, anaplastic, papilloma, and granulosa cell tumour. Immunohistochemical analysis revealed that CitH3 was strongly detected in all of the cancers assessed, while pan-deimination detection was overall low. Both PAD2 and PAD3 were the most predominantly expressed PADs across all of the cancers assessed, while PAD1, PAD4, and PAD6 were overall expressed at lower, albeit varying, levels. The findings from this pilot study provide novel insights into PAD-mediated roles in different cancers across a range of vertebrate species and may aid in the understanding of cancer heterogeneity and cancer evolution.

摘要

PADs 是一组依赖钙的酶,在炎症病理学中发挥关键作用,并且在癌症中有多种作用。PADs 导致精氨酸不可逆的翻译后修饰为瓜氨酸,导致不同细胞区室中蛋白质功能的变化。在脊索动物的系统发育过程中,PAD 同工酶的多样性不同,哺乳动物中有 5 种 PAD 同工酶,鸟类中有 3 种,鱼类中有 1 种。虽然 PADs 在各种人类癌症中的作用越来越多(既涉及癌症进展又涉及表观遗传调控),但对动物癌症的研究却很少。因此,目前的初步研究旨在评估整个系统发育树上一系列动物癌症中的 PAD 同工酶。此外,还评估了组织样本中的总蛋白脱亚胺化和组蛋白 H3 脱亚胺化(CitH3),CitH3 与人类癌症强烈相关,也表明基因调控变化和中性粒细胞细胞外陷阱形成(NETosis)。从一系列脊椎动物物种中选择了癌症:马、牛、驯鹿、绵羊、猪、狗、猫、兔子、貂、仓鼠、鹦鹉和鸭子。选择的癌症包括淋巴瘤、肾、肺、睾丸、神经内分泌、间变性、乳头瘤和颗粒细胞瘤。免疫组织化学分析显示,CitH3 在评估的所有癌症中均强烈检测到,而全脱亚胺化检测总体较低。在评估的所有癌症中,PAD2 和 PAD3 是表达最丰富的 PAD,而 PAD1、PAD4 和 PAD6 的表达总体较低,但变化不同。这项初步研究的结果为 PAD 在一系列脊椎动物物种中的不同癌症中的介导作用提供了新的见解,并可能有助于理解癌症异质性和癌症进化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/376cd5c156dc/ijms-23-08697-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/3eeeba5a5a8f/ijms-23-08697-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/0e3a4aba556d/ijms-23-08697-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/c859920d2a2a/ijms-23-08697-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/90a7975d6e65/ijms-23-08697-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/3460e4390ce9/ijms-23-08697-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/2eb6460d3fbb/ijms-23-08697-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/b092ad8560b7/ijms-23-08697-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/7e49e0f09237/ijms-23-08697-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/3b40a5baefb0/ijms-23-08697-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/f158b1f2bee4/ijms-23-08697-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/4800ad841686/ijms-23-08697-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/8a839df9b1a2/ijms-23-08697-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/fa165a19dc8d/ijms-23-08697-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/49a6c60a5417/ijms-23-08697-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/6f79c08dcee6/ijms-23-08697-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/4f5a924867b7/ijms-23-08697-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/650ef14320d2/ijms-23-08697-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/f95cfce77d23/ijms-23-08697-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/03948124ad4d/ijms-23-08697-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/5e57ce64ebc5/ijms-23-08697-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/7b394d6b3a56/ijms-23-08697-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/376cd5c156dc/ijms-23-08697-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/3eeeba5a5a8f/ijms-23-08697-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/0e3a4aba556d/ijms-23-08697-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/c859920d2a2a/ijms-23-08697-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/90a7975d6e65/ijms-23-08697-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/3460e4390ce9/ijms-23-08697-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/2eb6460d3fbb/ijms-23-08697-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/b092ad8560b7/ijms-23-08697-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/7e49e0f09237/ijms-23-08697-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/3b40a5baefb0/ijms-23-08697-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/f158b1f2bee4/ijms-23-08697-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/4800ad841686/ijms-23-08697-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/8a839df9b1a2/ijms-23-08697-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/fa165a19dc8d/ijms-23-08697-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/49a6c60a5417/ijms-23-08697-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/6f79c08dcee6/ijms-23-08697-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/4f5a924867b7/ijms-23-08697-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/650ef14320d2/ijms-23-08697-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/f95cfce77d23/ijms-23-08697-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/03948124ad4d/ijms-23-08697-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/5e57ce64ebc5/ijms-23-08697-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/7b394d6b3a56/ijms-23-08697-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a7a/9368843/376cd5c156dc/ijms-23-08697-g022.jpg

相似文献

1
A Pilot Study on Peptidylarginine Deiminases and Protein Deimination in Animal Cancers across Vertebrate Species.脊椎动物各物种动物癌症中肽基精氨酸脱亚氨酶和蛋白质脱亚氨作用的初步研究
Int J Mol Sci. 2022 Aug 4;23(15):8697. doi: 10.3390/ijms23158697.
2
Differential, Stage Dependent Detection of Peptidylarginine Deiminases and Protein Deimination in Lewy Body Diseases-Findings from a Pilot Study.路易体病中肽基精氨酸脱亚氨酶和蛋白质脱亚氨化的差异、阶段依赖性检测——一项初步研究的结果。
Int J Mol Sci. 2022 Oct 28;23(21):13117. doi: 10.3390/ijms232113117.
3
Post-translational protein deimination signatures in sea lamprey (Petromyzon marinus) plasma and plasma-extracellular vesicles.海七鳃鳗(Petromyzon marinus)血浆及血浆细胞外囊泡中的蛋白质翻译后脱亚氨基化特征
Dev Comp Immunol. 2021 Dec;125:104225. doi: 10.1016/j.dci.2021.104225. Epub 2021 Aug 3.
4
Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.使用 Cl-酰胺、PAD2、PAD3 和 PAD4 同工酶特异性抑制剂在胰腺癌细胞中应用肽基精氨酸脱亚氨酶抑制剂,揭示了 PAD2 和 PAD3 在癌症侵袭和细胞外囊泡特征调节中的作用。
Int J Mol Sci. 2021 Jan 30;22(3):1396. doi: 10.3390/ijms22031396.
5
Insights into peptidylarginine deiminase expression and citrullination pathways.关于肽基精氨酸脱亚氨酶表达和瓜氨酸化途径的研究进展。
Trends Cell Biol. 2022 Sep;32(9):746-761. doi: 10.1016/j.tcb.2022.01.014. Epub 2022 Feb 21.
6
Peptidylarginine deiminase and deiminated proteins are detected throughout early halibut ontogeny - Complement components C3 and C4 are post-translationally deiminated in halibut (Hippoglossus hippoglossus L.).在大比目鱼个体发育早期可检测到肽基精氨酸脱亚氨酶和脱亚氨蛋白质——在大比目鱼(大西洋庸鲽)中,补体成分C3和C4在翻译后发生脱亚氨作用。
Dev Comp Immunol. 2019 Mar;92:1-19. doi: 10.1016/j.dci.2018.10.016. Epub 2018 Nov 3.
7
Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.蛋白精氨酸脱亚氨酶(PADs):蛋白质瓜氨酸化的生化和化学生物学。
Acc Chem Res. 2019 Mar 19;52(3):818-832. doi: 10.1021/acs.accounts.9b00024. Epub 2019 Mar 7.
8
Citrullination and PAD Enzyme Biology in Type 1 Diabetes - Regulators of Inflammation, Autoimmunity, and Pathology.1 型糖尿病中瓜氨酸化和 PAD 酶生物学——炎症、自身免疫和病理的调节剂。
Front Immunol. 2021 Jun 1;12:678953. doi: 10.3389/fimmu.2021.678953. eCollection 2021.
9
Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme.肽基精氨酸脱亚氨酶翻译后脱亚精氨酸抑制素并调节多形性胶质母细胞瘤中外泌体释放和 microRNAs。
Int J Mol Sci. 2018 Dec 28;20(1):103. doi: 10.3390/ijms20010103.
10
Deimination Protein Profiles in Reveal Plasma and Extracellular Vesicle-Specific Signatures Relating to Immunity, Metabolic Function, and Gene Regulation.脱氨蛋白谱在 中揭示了与免疫、代谢功能和基因调控相关的血浆和细胞外囊泡特异性特征。
Front Immunol. 2020 Apr 28;11:651. doi: 10.3389/fimmu.2020.00651. eCollection 2020.

引用本文的文献

1
Animal Models of Human Disease 2.0.人类疾病动物模型2.0
Int J Mol Sci. 2024 Dec 23;25(24):13743. doi: 10.3390/ijms252413743.
2
Brain-Region-Specific Differences in Protein Citrullination/Deimination in a Pre-Motor Parkinson's Disease Rat Model.大脑区域特异性蛋白瓜氨酸化/脱亚胺化在运动前期帕金森病大鼠模型中的差异。
Int J Mol Sci. 2024 Oct 17;25(20):11168. doi: 10.3390/ijms252011168.
3
Differential, Stage Dependent Detection of Peptidylarginine Deiminases and Protein Deimination in Lewy Body Diseases-Findings from a Pilot Study.

本文引用的文献

1
Citrullination Was Introduced into Animals by Horizontal Gene Transfer from Cyanobacteria.瓜氨酸化是通过水平基因从蓝细菌转移到动物身上的。
Mol Biol Evol. 2022 Feb 3;39(2). doi: 10.1093/molbev/msab317.
2
Extracellular Vesicle Signatures and Post-Translational Protein Deimination in Purple Sea Urchin () Coelomic Fluid-Novel Insights into Echinodermata Biology.紫海胆()体腔液中的细胞外囊泡特征与翻译后蛋白质脱亚胺作用——对棘皮动物生物学的新见解
Biology (Basel). 2021 Sep 3;10(9):866. doi: 10.3390/biology10090866.
3
Neutrophil and Eosinophil Extracellular Traps in Hodgkin Lymphoma.
路易体病中肽基精氨酸脱亚氨酶和蛋白质脱亚氨化的差异、阶段依赖性检测——一项初步研究的结果。
Int J Mol Sci. 2022 Oct 28;23(21):13117. doi: 10.3390/ijms232113117.
霍奇金淋巴瘤中的中性粒细胞和嗜酸性粒细胞胞外诱捕网
Hemasphere. 2021 Sep 1;5(9):e633. doi: 10.1097/HS9.0000000000000633. eCollection 2021 Sep.
4
Post-translational protein deimination signatures in sea lamprey (Petromyzon marinus) plasma and plasma-extracellular vesicles.海七鳃鳗(Petromyzon marinus)血浆及血浆细胞外囊泡中的蛋白质翻译后脱亚氨基化特征
Dev Comp Immunol. 2021 Dec;125:104225. doi: 10.1016/j.dci.2021.104225. Epub 2021 Aug 3.
5
Histone citrullination: a new target for tumors.组蛋白瓜氨酸化:肿瘤的新靶点。
Mol Cancer. 2021 Jun 11;20(1):90. doi: 10.1186/s12943-021-01373-z.
6
Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.使用 Cl-酰胺、PAD2、PAD3 和 PAD4 同工酶特异性抑制剂在胰腺癌细胞中应用肽基精氨酸脱亚氨酶抑制剂,揭示了 PAD2 和 PAD3 在癌症侵袭和细胞外囊泡特征调节中的作用。
Int J Mol Sci. 2021 Jan 30;22(3):1396. doi: 10.3390/ijms22031396.
7
The roles of PAD2- and PAD4-mediated protein citrullination catalysis in cancers.蛋白精氨酸脱亚氨酶(PAD)2 和 PAD4 介导的蛋白瓜氨酸化催化作用在癌症中的作用。
Int J Cancer. 2021 Jan 15;148(2):267-276. doi: 10.1002/ijc.33205. Epub 2020 Aug 8.
8
A Novel Peptidylarginine Deiminase 4 (PAD4) Inhibitor BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma.一种新型的肽基精氨酸脱亚氨酶 4(PAD4)抑制剂 BMS-P5 可阻断中性粒细胞胞外诱捕网的形成并延缓多发性骨髓瘤的进展。
Mol Cancer Ther. 2020 Jul;19(7):1530-1538. doi: 10.1158/1535-7163.MCT-19-1020. Epub 2020 May 5.
9
Identification and Characterization of the Lactating Mouse Mammary Gland Citrullinome.鉴定和描述哺乳期小鼠乳腺瓜氨酸组。
Int J Mol Sci. 2020 Apr 10;21(7):2634. doi: 10.3390/ijms21072634.
10
Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines.肽基精氨酸脱亚氨酶同工酶特异性 PAD2、PAD3 和 PAD4 抑制剂在两种胶质母细胞瘤细胞系中差异调节细胞外囊泡特征和细胞侵袭。
Int J Mol Sci. 2020 Feb 22;21(4):1495. doi: 10.3390/ijms21041495.